Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Alexion Pharm Inc (ALXN)

Alexion Pharm Inc (ALXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 25,202,832
  • Shares Outstanding, K 221,291
  • Annual Sales, $ 4,131 M
  • Annual Income, $ 77,600 K
  • 60-Month Beta 1.67
  • Price/Sales 5.75
  • Price/Cash Flow 11.88
  • Price/Book 2.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 2.28
  • Number of Estimates 11
  • High Estimate 2.62
  • Low Estimate 2.13
  • Prior Year 1.95
  • Growth Rate Est. (year over year) +16.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
104.52 +8.96%
on 11/14/19
116.59 -2.32%
on 12/04/19
+7.26 (+6.81%)
since 11/06/19
3-Month
94.59 +20.40%
on 10/09/19
116.59 -2.32%
on 12/04/19
+10.05 (+9.68%)
since 09/06/19
52-Week
92.56 +23.04%
on 12/24/18
141.86 -19.72%
on 04/10/19
-7.15 (-5.91%)
since 12/06/18

Most Recent Stories

More News
Zacks.com featured highlights include: Alexion Pharmaceuticals, OpGen, Integer, ReWalk Robotics and Civeo

Zacks.com featured highlights include: Alexion Pharmaceuticals, OpGen, Integer, ReWalk Robotics and Civeo

CVEO : 0.84 (-0.70%)
ITGR : 79.24 (+2.80%)
ALXN : 113.89 (+6.02%)
OPGN : 1.17 (-1.68%)
RWLK : 2.51 (-0.40%)
Alexion Issues Statement on Path to Value Creation

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today issued the following statement on behalf of the Board of Directors and management team:

ALXN : 113.89 (+6.02%)
5 Discounted PEG Stocks for GARP Investors

Although PEG is categorized under value investing, it follows the principles of both growth and value investing.

SSW : 13.26 (+3.35%)
ALXN : 113.89 (+6.02%)
JAZZ : 149.46 (+0.92%)
THC : 35.53 (+3.68%)
EQH : 24.76 (+1.77%)
Adopt Rising P/E Technique With These 5 Top-Ranked Stocks

What bargain hunting? Stocks with a rising P/E can also be worth buying too.

CVEO : 0.84 (-0.70%)
ITGR : 79.24 (+2.80%)
ALXN : 113.89 (+6.02%)
OPGN : 1.17 (-1.68%)
RWLK : 2.51 (-0.40%)
ALXN vs. ILMN: Which Stock Is the Better Value Option?

ALXN vs. ILMN: Which Stock Is the Better Value Option?

ALXN : 113.89 (+6.02%)
ILMN : 326.47 (+2.08%)
Look for Shares of Alexion Pharm to Potentially Rebound after Yesterday's 1.06% Sell Off

Alexion Pharm (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $112.01 to a high of $114.96. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $112.22...

ALXN : 113.89 (+6.02%)
iCo Therapeutics Announces Third Quarter 2019 Financial Results

Vancouver, British Columbia--(Newsfile Corp. - December 2, 2019) - iCo Therapeutics ("iCo" or the "Company"),today reported financial results for the Quarter ended September 30, 2019. Amounts, unless...

ALXN : 113.89 (+6.02%)
ICO.VN : 0.060 (unch)
ICOTF : 0.0404 (-2.18%)
Rigrodsky & Long, P.A. Files Class Action Suit Against Achillion Pharmaceuticals, Inc.

Rigrodsky & Long, P.A.:

ACHN : 6.17 (+0.33%)
ALXN : 113.89 (+6.02%)
Biotech Stock Roundup: CBAY Falls, CCXI Gains, Amgen Acquires Otezla & More

Key highlights of the past week include regulatory and pipeline updates.

GBT : 79.35 (+4.20%)
ALXN : 113.89 (+6.02%)
ICPT : 107.48 (-10.27%)
BIIB : 300.26 (+0.29%)
AMGN : 233.77 (+0.15%)
CCXI : 31.28 (+0.74%)
CBAY : 1.75 (+5.42%)
It's Been a Particularly Exciting Year for Biotech Stocks Across the Board

The biotech sector continues to grow as valuations are sky high, based on recent M&A's within the industry. 2019 started off with a boom with the announcement of two multi-billion-dollar deals valued at...

ONCY : 1.14 (unch)
CCXI : 31.28 (+0.74%)
AKRO : 22.99 (+4.22%)
ALXN : 113.89 (+6.02%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Bearish.

See More Share

Trade ALXN with:

Business Summary

Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes...

See More

Key Turning Points

2nd Resistance Point 117.96
1st Resistance Point 115.92
Last Price 113.89
1st Support Level 110.72
2nd Support Level 107.56

See More

52-Week High 141.86
Fibonacci 61.8% 123.03
Fibonacci 50% 117.21
Last Price 113.89
Fibonacci 38.2% 111.39
52-Week Low 92.56

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar